PJ

Payal Jaynesh Patel

Active Director Director DIN 03579955
DIN 03579955 First appointment Jul 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2011
Shareholding value •••• Premium profile

About Payal Jaynesh Patel

Data last updated:

Payal Jaynesh Patel is a Director at Ticos Laboratories Private Limited (since 2019), Director at Ticos Lifesciences Limited (since 2011) and Director at Ticos Omega Pharmaceuticals Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9.39 Cr; the largest is Ticos Laboratories Private Limited at ₹4.78 Cr (FY 2022). Earlier, Payal Jaynesh Patel was a Director at Api Webtrade Private Limited (from 2019).

DIN 03579955
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2011
Oldest Company Age 18 yrs
Largest company Ticos Laboratories Private Limited · ₹4.78 Cr (FY 2022)
Combined revenue ₹9.39 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ticos Laboratories Private Limited U24239GJ2010PTC060303
Director16 Mar 20192010₹4.78 Cr (FY 2022)Active
Ticos Lifesciences Limited U24239GJ2008PLC053283
Director22 Jul 20112008₹4.61 Cr (FY 2022)Active
Director03 Feb 20202020Active
Designated Partner27 May 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Api Webtrade Private Limited U74120GJ2015PTC083392
Director16 Mar 20192015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ticos Omega Pharmaceuticals Private Limited
Ticos Lifesciences Limited
Ticos Laboratories Private Limited
Api Webtrade Private Limited
Premium access

Shareholding and investment profile for Payal Jaynesh Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payal Jaynesh Patel

Payal Jaynesh Patel currently holds 4 directorships: Ticos Laboratories Private Limited (Director, since 16 Mar 2019, revenue ₹4.78 Cr (FY 2022)); Ticos Lifesciences Limited (Director, since 22 Jul 2011, revenue ₹4.61 Cr (FY 2022)); Ticos Omega Pharmaceuticals Private Limited (Director, since 03 Feb 2020); Ticos Holding Llp (Designated Partner, since 27 May 2016).

Payal Jaynesh Patel was first appointed on 22 Jul 2011 as Director at Ticos Lifesciences Limited. The most recent appointment on record is 03 Feb 2020 at Ticos Omega Pharmaceuticals Private Limited.

The 2 current companies of Payal Jaynesh Patel that report revenue have a combined latest revenue of ₹9.39 Cr: Ticos Laboratories Private Limited ₹4.78 Cr (FY 2022); Ticos Lifesciences Limited ₹4.61 Cr (FY 2022).

Payal Jaynesh Patel held 1 earlier board appointment: Api Webtrade Private Limited (Director, from 16 Mar 2019).

The current boards of Payal Jaynesh Patel's companies include Jaynesh Ratilal Patel (Ticos Laboratories Private Limited), Pravinchandra Samjibhai Bhuva (Ticos Lifesciences Limited), Sureshkumar Dharmdas Parmar (Ticos Lifesciences Limited), Hiren Harsukhray Raval (Ticos Omega Pharmaceuticals Private Limited), Jayesh Harsukhray Raval (Ticos Omega Pharmaceuticals Private Limited), Mitesh Harsukhray Raval (Ticos Omega Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available